Sergiu Emil Georgescu

University of Bucharest

Papers

1

Total Citations

64

H-Index

1

About

Dr. Sergiu Emil Georgescu is at the forefront of integrating artificial intelligence with liquid biopsy technologies to revolutionize colorectal cancer (CRC) diagnostics. His pioneering work focuses on developing non-invasive, AI-driven methods for early cancer detection and patient stratification, addressing the critical challenge that CRC prognosis remains tightly linked to the stage at diagnosis. His landmark 2022 paper, "Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies," has already garnered 64 citations, underscoring its impact on the field. By combining machine learning algorithms with circulating biomarker analysis, Dr. Georgescu’s research aims to shift CRC management from late-stage intervention to early, actionable detection—a paradigm that could significantly improve survival rates. His contributions are particularly vital in an era where CRC remains the second most diagnosed cancer globally, offering a modern, precision-based approach to a persistent public health burden. Through this interdisciplinary work, Dr. Georgescu is shaping the future of oncological diagnostics, bridging computational science and clinical oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
64
Total Citations
64
Avg Citations/Paper
🏆 Most Cited Paper
Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient’s Stratification
64 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: University of Bucharest

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago